Literature DB >> 26385128

Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A.

J González-Ramos1, M L Alonso-Pacheco2, B Goiburú-Chenú3, A Mayor-Ibarguren2, P Herranz-Pinto2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26385128     DOI： 10.1111/bjd.14180

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  [Axillary and perimamillary Fox-Fordyce disease (apocrine miliaria) in a 19-year-old woman].

Authors:  S Hanner; R Schneiderbauer; A Enk; F Toberer
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

Review 2.  New Uses of AbobotulinumtoxinA in Aesthetics.

Authors:  Joel Schlessinger; Erin Gilbert; Joel L Cohen; Joely Kaufman
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

Review 3.  Antipruritic Effects of Botulinum Neurotoxins.

Authors:  Parisa Gazerani
Journal:  Toxins (Basel)       Date:  2018-03-29       Impact factor: 4.546

4.  Fox-Fordyce disease: report of two cases with perifollicular xanthomatosis on histological image.

Authors:  María Elisa Vega-Memije; Diego Olin Pérez-Rojas; Leticia Boeta-Ángeles; Patricia Valdés-Landrum
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

5.  Refractory pruritic Fox-Fordyce disease successfully treated with botulinum toxin type A.

Authors:  Meshal Mohammad Alhameedy; Muhammad Usman Tariq
Journal:  Int J Womens Dermatol       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.